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Abstract
Background: The ε4 allele of the apolipoprotein E gene (APOE-ε4) is the strongest genetic factor for late-onset
Alzheimer’s disease. During middle age, cognitively healthy APOE-ε4 carriers already show several brain alterations
that resemble those of Alzheimer's disease (AD), but to a subtler degree. These include microstructural white matter
(WM) changes that have been proposed as one of the earliest structural events in the AD cascade. However,
previous studies have focused mainly on comparison of APOE-ε4 carriers vs noncarriers. Therefore, the extent and
magnitude of the brain alterations in healthy ε4 homozygotes, who are the individuals at highest risk, remain to be
characterized in detail.
Methods: We examined mean, axial, and radial water diffusivity (MD, AxD, and RD, respectively) and fractional
anisotropy in the WM as measured by diffusion-weighted imaging in 532 cognitively healthy middle-aged
participants from the ALFA study (ALzheimer and FAmilies) cohort, a single-site population-based study enriched
for AD risk (68 APOE-ε4 homozygotes, 207 heterozygotes, and 257 noncarriers). We examined the impact of age
and APOE genotype on these parameters using tract-based spatial statistics.
Results: Healthy APOE-ε4 homozygotes display increased WM diffusivity in regions known to be affected by AD.
The effects in AxD were much smaller than in RD, suggesting a disruption of the myelin sheath rather than pure
axonal damage.
Conclusions: These findings could be interpreted as the result of the reduced capacity of the ε4 isoform of the
APOE protein to keep cholesterol homeostasis in the brain. Because cerebral lipid metabolism is strongly related to
the pathogenesis of AD, our results shed light on the possible mechanisms through which the APOE-ε4 genotype is
associated with an increased risk of AD.
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Background
The ε4 allele of the apolipoprotein E gene (APOE-ε4) is the
strongest genetic factor for late-onset Alzheimer’s disease.
Compared with those individuals with an APOE ε3/ε3
genotype, white individuals with one copy of the ε4 allele
show an increased lifetime risk of developing Alzheimer's
disease (AD) (ε2/ε4, OR 2.6; ε3/ε4, OR 3.2). The risk is
much higher for carriers of two copies (ε4/ε4, OR 14.9) [1].
The main roles of the ApoE protein, encoded by the APOE
gene, include lipid transport and clearance of amyloid de-
position. However, the ε4 isoform of the ApoE protein
shows an impaired capacity to perform these functions
compared with the other isoforms [2]. Such impaired func-
tion may underlie the observed effects of APOE-ε4 on the
brain throughout the lifespan. In particular, APOE-ε4 has
been related to earlier and increased amyloid-β deposition,
one of the neuropathological hallmarks of AD [3, 4].
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However, the effects on brain morphology have been re-
ported to be subtler [5]. Most of the studies so far have
stratified individuals in only two levels of risk (APOE-ε4
carriers vs noncarriers). However, APOE-ε4 homozygotes,
who completely lack expression of the most efficient iso-
form of the ApoE protein, are an interesting population to
study to gain a better understanding of the mechanisms
through which APOE genotype modulates the risk of AD.
Given the essential implication of ApoE in the transport of
cholesterol, the main component of the myelin sheath, it is
conceivable that alterations in white matter (WM) micro-
structure may be one of these mechanisms.
The last decade has seen increasing interest in the
study of brain microstructure measured using diffusion
magnetic resonance imaging (dMRI). Water molecules
are locally influenced by existing axon fibers [6], and
their movements properties can be described by a set of
measures generally including fractional anisotropy (FA),
mean diffusivity (MD), axial diffusivity (AxD), and radial
diffusivity (RD). Variations in these parameters can cap-
ture microstructural changes such as axonal loss, inflam-
mation, Wallerian degeneration [7], demyelination, or
fiber damage [8], and their alteration is likely to hinder
transfer of information across networks, eventually lead-
ing to cognitive impairment [9–13].
There is a growing body of evidence supporting the as-
sociation between APOE-ε4 status and WM integrity in
cognitively normal subjects as measured using diffusion
(or relaxation) parameters. The nature of this associ-
ation, however, is still under debate. WM alterations
have been detected in individuals at genetic risk of AD
[14–18]. Persson et al. and Honea et al. [15, 17] reported
decreased anisotropy in ε4 carriers compared with non-
carriers. Heise et al. [14] compared two groups compris-
ing young (aged 20–35 years) and old (aged 50–78
years) participants (N = 73) and found a general reduc-
tion of FA and a general increase in MD in ε4 carriers.
Westlye et al. [18] observed widespread increases in MD
and RD in carriers of the ε4/ε3 alleles compared with
ε3/ε3 in 203 volunteers aged 21.1–69.9 years. Recently,
Cavedo et al. [19] studied 74 participants (mean age
67.85 years) and found a significant reduction of FA and
increase in RD in ε4 carriers vs noncarriers.
Some researchers have described a genotypic effect
that remains stable throughout life, with ε4 carriers
showing local increased diffusivity and lower FA in an
age-independent manner [14–18]. In contrast, other
studies have suggested that APOE instead impacts the
trajectory of age-related changes [12, 20], with ε4 car-
riers showing accelerated diffusion changes across the
older adult age range. Assessing interaction between age
and genotype is challenging without a longitudinal de-
sign, as reflected by the inconsistency in the findings
from these cross-sectional datasets [21]. Regarding these
previous studies, it is worth noting the large existing
variability in the age range of the participants, the ROIs,
the sample size, the number of ε4 carriers, or the
employed methodology.
WM alterations have also been found in patients
with AD [22] and patients with mild cognitive im-
pairment [23, 24]. Interestingly, it has been proposed
that APOE may play a role in modulating the focal-
ity of these alterations [25]. Such microstructural ef-
fects on WM add to the well-known effect of APOE
on gray matter (GM) morphology across the AD
continuum [26, 27], driving the neuroanatomical
expression of the most common variant AD pheno-
types [28], or even in cognitively healthy middle-
aged individuals [29]. However, only a few studies
have described WM differences in the preclinical
state of the disease (i.e., cognitively healthy individ-
uals with altered amyloid biomarkers) by addressing
the hypothesis that the preclinical state of AD is dis-
tinct from normal aging [30–32]. Their final conclu-
sions unanimously identified dMRI metrics as
promising markers of early degeneration, potentially
predating changes at a macrostructural level. A sum-
mary of the studies examining the APOE polymor-
phisms ε2/ε3/ε4 and WM integrity using dMRI are
listed in Table 1 [33].
The purpose of the present study was to add to the
existing literature by evaluating genotype-related differ-
ences in WM integrity as captured by diffusion parame-
ters in a cohort of cognitively normal middle-aged
individuals at three levels of AD risk (noncarriers, ε4
heterozygotes, and ε4 homozygotes). We hypothesized
that subjects at higher risk of developing AD would
show more pronounced age-related changes and there-
fore more negatively affected microstructure. Such
changes would manifest mainly as higher diffusivity in
APOE-ε4 carriers, especially among homozygotes. FA is
not expected to be significantly altered in this population
comprising middle-aged cognitively healthy participants.
We hypothesized that these changes may appear in re-
gions involved in AD pathogenesis, in particular along
bilateral long associative tracts. The present cohort also
allowed us to recruit an unprecedented number of indi-
viduals homozygous for the ε4 risk allele for a single-site
cohort to better understand this allele’s neurobiological
impact on brain microstructure. We analyzed DW para-
metric maps—namely FA, MD, RD, and AxD—using a
skeleton-based approach focused on WM tracts. We
assessed effects of APOE-ε4 load, status, age, and sex.
Age by genotype interaction was also tested. Given some
previous reports in the literature showing associations
between cognitive functions and the integrity of the
WM, the effect of educational attainment was also
assessed on every parameter.
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Methods
Study participants
The recruitment for the study consisted of two steps.
First, 2743 cognitively healthy volunteers aged between
45 and 74 years were enrolled in the ALFA study (ALz-
heimer and FAmilies), a large cohort program aimed at
identifying neuroimaging biomarkers of preclinical AD
in the general population [34]. Exclusion criteria in-
cluded performance below established cutoffs for a num-
ber of cognitive tests as well as the presence of any
psychiatric or any other clinically significant condition
[34]. Second, after APOE genotyping, all participants
homozygous for the ε4 allele and all carriers of the ε2 al-
lele were invited to undergo magnetic resonance imaging
(MRI), along with ε4-heterozygous and noncarriers
matched for age and sex. This sampling strategy resulted
in 576 study participants, 44 of whom had to be ex-
cluded because of either MRI incidental findings or poor
image quality, resulting in a final sample size of 532.
Demographic characteristics of the participants are sum-
marized in Table 2.
For the statistical analyses, participants were pooled ac-
cording to the cumulative number of ε4 alleles, that is, non-
carriers as well as ε4-heterozygous and ε4-homozygous
individuals. However, homozygous subjects were significantly
younger than noncarriers and heterozygotes (Table 1). For
this reason, age was included as a covariate in all subsequent
analyses. In order to account for potential bias due to these
differences, a secondary analysis was also performed using
age-matched subgroups. The study was approved by the
local ethics committee, and all participants provided written
informed consent to participate in the study.
APOE genotyping
Total DNA was obtained from the blood cellular
fraction by proteinase K digestion followed by alcohol
precipitation. Samples were genotyped for two single-
nucleotide polymorphisms (rs429358 and rs7412) deter-
mining the possible APOE isoforms ε1, rs429358 (C) +
rs7412 (T); ε2, rs429358 (T) + rs7412 (T); ε3, rs429358
(T) + rs7412 (C); and ε4, rs429358 (C) + rs7412 (C). Of
the 532 participants, 162 were ε3/ε4 carriers, 153 were
homozygous for the ε3 allele, 104 were ε2/ε3 carriers, 68
were homozygous for the ε4 allele, and 45 were ε2/ε4. The
allele frequencies were in Hardy-Weinberg equilibrium.
Image data acquisition
All brain MRI data were acquired on a single standard
3-T scanner (GE Discovery MR750w; GE Healthcare Life
Sciences, Marlborough, MA, USA). The dMRI proto-
col employed a spin-echo echo-planar imaging se-
quence with one T2-weighted baseline (b = 0 s·mm− 2),
64 b = 1000 s·mm− 2 DW volumes acquired with 64
distinct diffusion-encoding directions. The field of view was
256 × 256 mm, and the imaging matrix was 128 × 128 with
56 slices and slice thickness 2 mm, giving 2-mm isotropic
voxels.
Image processing
DW images were first corrected for eddy current distor-
tions and then denoised with the overcomplete local
PCA method described by Manjón et al. [35]. Data ana-
lysis was then performed using tools from the FMRIB
Software Library software suite [36] (http://www.fmrib.
ox.ac.uk/fsl). FA, MD, AxD, and RD maps were gener-
ated using DTIFit, which is part of FSL that fits a diffu-
sion tensor model at each voxel. The FA output images
were used as input for tract-based spatial statistics
(TBSS) [37]. All subjects’ FA data were coregistered to a
common space using FMRIB’s Non-linear Image Regis-
tration Tool. A mean FA image was generated, and a
mean FA skeleton was created using TBSS, which repre-
sents the centers of all tracts common to the group. The
mean skeleton was thresholded and binarized at FA
> 0.2. Each subject’s aligned FA data were then projected
onto this skeleton, and the resulting data were fed into
voxelwise general linear model cross-subject statistics.
Similar warping and analyses were used for each para-
metric map (FA, MD, AxD, and RD) using the FA skel-
eton as a reference template.
Table 2 Sample characteristics
Total sample (N = 532) NC (n = 257) HE (n = 207) HO (n = 68) Inferential statistics
Mean SD Mean SD Mean SD Mean SD
Age, years 58.13 7.46 58.52 7.62 58.71 7.41 54.94 6.22 F = 7.37; p < 0.01
Education, years 13.61 3.54 13.61 3.60 13.59 3.52 13.38 3.48 F = 0.19; p = 0.83
MMSE score 29.06 1.05 29.00 1.12 29.02 1.11 29.26 0.78 F = 1.45; p = 0.24
TFRa 16.46 5.16 16.32 5.20 16.24 5.09 17.73 5.16 F = 2.25; p = 0.11
TPRa 24.13 4.48 23.83 4.85 24.16 4.19 25.19 3.71 F = 2.36; p = 0.10
Males/females, n 211/321 92/165 94/113 25/43 χ2 = 4.79; p = 0.09
Abbreviations: NC Noncarriers; HE ε4-Heterozygous; HO ε4-Homozygous; MMSE Mini Mental State Examination; TPR Total paired recall; TFR Total free recall
aFull evaluation of cognitive performance was not available for 16 subjects
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Statistical analysis
Group-related differences were assessed using a voxel-
by-voxel permutation nonparametric test (5000 permu-
tations) with threshold-free cluster enhancement, per-
formed using the Randomise tool available in FSL [38].
All results are shown at the p < 0.05 significance level
corrected for multiple comparisons across space. Cor-
rection for multiple testing was applied using the default
familywise error rate control with threshold-free cluster
enhancement as implemented in Randomise and as de-
scribed elsewhere [38, 39]. For each of the four diffusion
parameters (MD, FA, RD, and AxD), we performed a
voxelwise multiple linear regression analysis using two
main models, the first one to measure the effect of the
APOE genotype on diffusion parameters and the second
to model the interaction with age on top of the main ef-
fect of genotype. We partitioned genetic variance by in-
cluding three dummy regressors coding for the number
of ε4 alleles carried. The first model included age and
sex as confounding variables. The second one included
only sex, because age-by-genotype interaction was the
effect of interest. Separate t test contrast weights were
specified to compare MD, FA, RD, and AxD maps to as-
sess the different components of the effects of the
APOE-ε4 genotype among dominance (ε4 carriers vs
noncarriers), recessivity (homozygotes vs others), and
additivity (correlation with the number of ε4 alleles car-
ried) in both directions.
Supplementary analyses
These analyses were completed by performing a set of
supplementary experiments intended to control for po-
tential confounding effects in our dataset. In order to
control for the observed difference in age between APOE
ε4 homozygotes and other subjects, we performed an
additional analysis using exactly the same protocol as
described in the two preceding subsections, but we re-
stricted it to an age-matched subsample. Also, to discard
the potential influence of the ε2 allele in the group of ε4
noncarriers, ε2 carriers were left out of this subsample.
The resulting dataset amounted to 65 noncarriers ε3/ε3,
65 APOE ε4 heterozygotes ε3/ε4, and 65 APOE ε4
homozygotes. Results of this analysis are presented in
Additional file 1: Appendix A.
An additional voxel-wise whole-brain analysis was per-
formed using the Statistical Parametric Mapping (SPM)
suite to explore the possible extensions of our results re-
leasing the skeleton-based spatial constraint and using
the exact same statistical models. Methods and results
are detailed in Additional file 1: Appendix B. To rule out
any potential local effects of white matter hyperintensi-
ties (WMH), a complementary analysis was performed,
masking out any voxel segmented as WMH in any sub-
ject of the studied sample. WMH masks were segmented
from fluid-attenuated inversion recovery images of the
same individuals using a method described previously
[40]. Global effects of WMH load were also assessed by
introducing global WMH volumes and Fazekas scores as
confounders in the statistical models. Finally, the level of
educational attainment was assessed as an additional po-
tential confounder.
Results
Effect of APOE genotype
We found significant main effects of APOE-ε4 on MD,
RD, and AxD, whereas no significant effect of the risk
variant on FA was detected. Figure 1a shows the TBSS
map for MD resulting from the recessive contrast, where
APOE-ε4 homozygotes displayed increased parametric
value compared with both noncarriers and heterozygotes
in extended bilateral regions of the skeletonized WM,
including, in decreasing order of cluster size, corona
radiata, superior longitudinal fasciculus (SLF), inferior
longitudinal fasciculus (ILF), inferior fronto-occipital fas-
ciculus (IFOF), and corticospinal tract. Interestingly, we
also found a significant additive effect of APOE-ε4 on MD,
which was more pronounced in the right hemisphere
along the SLF and ILF and the IFOF (Fig. 1b). The con-
trast assessing the dominance effect (APOE-ε4 noncarriers
vs others) did not yield significant group differences.
Consistent with the results for MD, we found signifi-
cantly increased RD and AxD in APOE-ε4 homozygotes
in both the recessive (homozygotes vs others) and additive
contrasts (positive association with the number of ε4 al-
leles), whereas no significant effects were detected in the
dominant contrast (noncarriers vs others). RD increases
followed a pattern very close to that of MD (Fig. 2).
Regions showing a recessive effect included bilateral
SLF, ILF, IFOF, and forceps minor, with 83% of suprathres-
hold voxels shared between RD and MD (Fig. 2a). Clusters
demonstrating an additive effect shared again over 88% of
suprathreshold voxels with MD (Fig. 2b). Regions showing
AxD increases in APOE-ε4 were less extended and stronger
in the right hemisphere (Fig. 3). Clusters suggesting a reces-
sive effect appeared in regions such as right SLF, right IFOF,
and right corticospinal tract in decreasing order of spatial
extent, sharing 15% of significant voxels with MD (Fig. 3a).
Finally, an additive effect was found in regions similar to
those in the recessive map. However, these regions were
much more reduced in spatial extent with an 11% of overlap
with significant voxels observed with MD (Fig. 3b). Values
derived from these significant clusters are plotted in Figs. 4
and 5 with respect to age and genotype group for MD, RD,
and AxD.
In all the analyses performed, APOE-ε4 homozygotes
never significantly showed lower levels in MD, RD, and
AxD, and they did not show higher levels in FA. Levels
in FA did not significantly differ between groups in our
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Fig. 1 Effect of APOE on mean diffusivity (MD) (from top to bottom: recessive and additive components). No dominant component was observed.
Only contrast maps associated with higher MD in ε4 carriers showed significant voxels. The white matter skeleton is shown in green. Suprathreshold
clusters are presented in colors from dark red to white (1 − p > 0.95, familywise error rate- and threshold-free cluster enhancement-corrected)
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Fig. 2 Effect of APOE on radial diffusivity (RD) (from top to bottom: recessive and additive components). No dominant component was observed.
Only contrast maps associated with higher RD in ε4 carriers showed significant voxels. The white matter skeleton is shown in green. Suprathreshold
clusters are presented in colors from dark red to white (1 − p > 0.95, familywise error rate- and threshold-free cluster enhancement-corrected)
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Fig. 3 Effect of APOE on axial diffusivity (AxD) (from top to bottom: recessive and additive components). No dominant component was observed.
Only contrast maps associated with higher AxD in ε4 carriers showed significant voxels. The white matter skeleton is shown in green. Suprathreshold
clusters are presented in colors from dark red to white (1 − p > 0.95, familywise error rate- and threshold-free cluster enhancement-corrected)
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dataset in either a recessive or a dominance effect. No
significant interaction between age and genotype was
observed for any of the analyses performed. Table 3
summarizes the tracts for which APOE status showed a
significant impact on one or more diffusion metrics.
Effect of other factors
MD, RD, and AxD increased with age in the vast majority
of the skeletonized WM, demonstrating previously well-
documented results regarding age-related changes in dif-
fusivity (Fig. 6). On the contrary, FA decreased with age in
extensive regions but also showed a significant age-related
increase in bilateral corticospinal tracts (Fig. 7).
Educational attainment showed no significant effect
on any of the diffusion parameters. No voxel demon-
strated a significant association between any para-
metric map and global volumes of WM lesions or
Fazekas scores in this dataset. Similarly, no global or
regional effect of WMH load was detected in these
respective complementary analyses.
Matched sample analysis
In a similar fashion as in the initial full dataset, ε4 ho-
mozygotes showed increased values in MD, RD, and
AxD as compared with other subjects. Consistent with
our initial results, significant clusters appeared in regions
such as SLF, IFOF, and forceps minor in decreasing
order of spatial extent. Again, differences measured in
RD were more extended than in AxD. ε4 Homozygotes
also had significantly lower FA than other subjects in re-
gions including forceps minor, bilateral IFOF, SLF, and
anterior thalamic radiations. This difference was not ob-
served initially in the original whole dataset. Contrast
maps are presented in Additional file 1: Figures S1 to S4.
Fig. 4 Effect of aging and APOE genotype on diffusion parameters (in seconds per mm2) on significant voxels in the recessive contrast. Left:
Scatterplots of regional diffusivity across subjects (MD, RD, and AxD from top to bottom) regressed by age (solid lines). Right: Box plots based on
genotype groups (ε4 homozygotes [HO], ε4 heterozygotes [HT], and noncarriers [NC] from left to right). Asterisks depict significance after a post
hoc t test (p < 0.001, uncorrected)
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Whole-brain voxel-wise analysis
APOE-ε4 homozygotes showed significantly increased
MD as compared with other subjects. Significant clusters
were found bilaterally in the WM essentially in SLF
(Additional file 1: Figure S5). FA compared between
genotype groups revealed no significant differences, in
line with our results obtained using TBSS on the whole
dataset.
Discussion
The present study points to the existence of WM micro-
structural changes in cognitively normal adults carrying
the ε4 allele. This effect was significant when we tested
both the recessive and additive models. These results sug-
gest that the ε4 allele adds extra burden to known age-
related changes, especially for those individuals carrying
two copies of the risk allele. In the brain, the APOE pro-
tein mediates neuronal delivery of cholesterol, which is an
essential component for axonal growth, synaptic forma-
tion, and remodeling [2]. Because the ApoE-ε4 isoform of
the protein is less efficient than ApoE-ε3 and ApoE-ε2 in
transporting brain cholesterol [41], our findings could be
interpreted as the result of a dysregulation in cholesterol
homeostasis, which might contribute to the increased risk
of AD observed in the ε4-homozygous group.
In support of this interpretation, it is worth noting that
findings in RD and AxD show distinct patterns. Differences
in RD but not in AxD are quite typically reported in AD risk
studies [14, 16, 18, 42]. Considering that changes in AxD (in
addition to RD increases and FA decreases) are observed in
symptomatic AD, this would strengthen the idea that both
correspond to distinct stages of WM degeneration. The
Fig. 5 Effect of aging and APOE genotype on diffusion parameters (in seconds per mm2) on significant voxels in the additive contrast. Left:
Scatterplots of regional diffusivity across subjects (MD, RD, and AxD from top to bottom) regressed by age (solid lines). Right: Box plots based on
genotype groups (ε4 homozygotes [HO], ε4 heterozygotes [HT], and noncarriers [NC] from left to right). Asterisks depict significance after a post
hoc t test (p < 0.001, uncorrected)
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smaller effects in AxD than in RD in healthy at-risk partici-
pants would suggest a disruption of the myelin sheath rather
than pure axonal damage [42, 43]. A plausible explanation of
this finding is that APOE-ε4 homozygotes, who lack expres-
sion of the more functional isoforms of the protein, have
thinner myelin sheaths that what would correspond to their
age. A thinner myelin sheath would decrease the electrical
isolation of the axons, thus negatively influencing transmis-
sion speed [44] and demanding a higher metabolic con-
sumption to sustain neurotransmission [45]. Such an effect
would be in addition to the metabolic deficits associated to
APOE-ε4 even in cognitively healthy populations [46, 47].
Therefore, increased metabolic demand coupled with an im-
paired neuroenergetic capability might explain the observed
WM microstructural changes accelerating the effects of
aging of WM microstructure in the APOE-ε4 homozygous
group and would render this group more vulnerable to brain
insults associated with AD. For instance, impaired cerebral
metabolism could compromise the ability of microglia to re-
move amyloid deposition and might underlie the observed
earlier and faster rate of amyloid accumulation in APOE-ε4
homozygotes [3].
The effects of APOE are essentially observed in regions
known to be targets of AD pathology. Among them, SLF fi-
bers showed the largest effect and are indeed known to be
affected in AD [20, 24, 48–50] and in mild cognitive im-
pairment [2, 22]. Effects appear stronger in posterior re-
gions including the temporal and parietal lobes, whereas a
number of studies demonstrated widespread effects, includ-
ing frontal regions [12, 51]. Ryan et al. interpreted such
widespread effects as a combination between ε4-related ef-
fects, which affect more posterior regions, and normal
aging-related effects, which involve more frontal regions.
On one hand, the younger age of the participants in the
present study may partially explain the predominance of
posterior changes because genotypic effects would predom-
inate over age-related changes. On the other hand, the fact
that posterior WM corresponds mainly to late-myelinating
fiber pathways is in line with the retrogenesis model pro-
posed by some authors [50, 52]. This model proposes that
brain regions that are myelinated later in development tend
to be more vulnerable to age-related damage. These regions
include cortical association areas that recapitulate the
spatial spread of AD lesions in reverse [53] and which sup-
port the cognitive functions that decline earlier in AD [54].
The differences partition into recessive and additive com-
ponents. Recessive contrasts show larger clusters, but all
significant voxels from recessive contrast maps include the
ones from additive maps. Hence, the strongest differences
that emerged in our dataset discriminate the homozygotes
Fig. 6 Effect of age on mean diffusivity. The white matter skeleton is shown in green. Suprathreshold clusters are presented in colors from dark
red to white (1 − p > 0.95, familywise error rate- and threshold-free cluster enhancement-corrected)
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against other subjects. This stands out from a number of
reported results about carriers differing from noncarriers
[14, 18, 19], which would consequently suggest the exist-
ence of a rather dominant effect (with one or two copies of
the risk allele). This difference may find explanation in the
specific age ranges and distributions of the studied samples,
most of which are older than in the present study. In such
way, younger ε4 homozygotes in our study might be
showing a behavior similar to older heterozygotes in other
studies. In this regard, even though the genotypic effect
Fig. 7 Effect of age on fractional anisotropy. The white matter skeleton is shown in green. Suprathreshold clusters are presented in colors from
dark red to white (1 − p > 0.95, familywise error rate- and threshold-free cluster enhancement-corrected)
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observed in the present study does not interact with age,
this same effect may become apparent in heterozygotes of
older age. It is also worth noting that these studies opt for
pooling ε4 carriers together, generally by lack of sufficient
ε4 homozygotes, to be able to keep them as a distinct
group. In the present study, the high number of homozy-
gotes allowed us to study them as an individual group and
to differentiate additive from recessive effects.
No significant differences in FA emerged between
genotypic groups in our dataset. In contrast, researchers
in a number of studies [12, 14–17, 19] have reported de-
creased anisotropy in cognitively healthy ε4 carriers. A
possible explanation for this may again derive from the
age ranges represented in these studies. Participants in
our dataset, especially those at risk of developing AD,
are at an early stage where FA is still not sensitive
enough to measure WM alteration. Moreover, Acosta-
Cabronero et al. [55] pointed out a possible scenario
where absolute diffusivities increase with FA remaining
stable because these parameters are mathematically re-
lated. Our results may be a plausible example of this sce-
nario, and we hypothesize that when moving toward
later stages, differences in FA, only emerging as stable
trends in our data, will become significant. Interestingly,
we observed possible evidence of this difference in FA
when performing the same analysis on a smaller sub-
sample using age-matched genotype groups, where ho-
mozygotes ε4 carriers revealed decreased anisotropy
compared with other subjects.
Some groups of subjects revealed significant demo-
graphic differences in our dataset. In particular, homozy-
gotes appeared to be significantly younger than others.
Given the usual known direction of age-related changes
on diffusion tensor imaging (DTI) parameters, the young
age of these participants may give them an advantage by
adding a “protective effect” (though assuming the ab-
sence of any pleiotropic expression of APOE) and may
therefore hinder findings related to genotypic influence.
Despite such heterogeneity in the dataset, these subjects
still showed significant changes as compared with others.
Previous researchers also investigated a potential pro-
tective effect attributed to the ε2 allele. To account for
the potential influence of these two factors (age differ-
ence and ε2 allele), the same analytical protocol was run
on a subsample consisting of three age-matched groups
excluding ε2 carriers. As described in Additional file 1:
Appendix A, results from this supplementary analysis
were rigorously in line with those obtained with the ori-
ginal dataset. This confirms the earliness of the burden
associated with APOE-ε4 homozygotes while discarding
any influence from the ε2 allele. The number of ε2 car-
riers in our dataset remains far from being sufficient to
allow us to assess the specific advantage attributed to
this allele. Other modifiable risk factors may contribute
to the changes measured in the WM microstructure. In
particular, in this work, we evaluated the effect of educa-
tional attainment and found no significant voxel. Be-
cause pathological hyperintensities may also affect WM
under the influence of cardiovascular and genotypic risk
factors, associations between diffusion parameters and
Fazekas scores or volumes of WM lesions were assessed
and no association emerged. The explanation for this
lack of influence may lie in the low burden of WM
hyperintensities found in our sample.
Although having been studied in the WM for the most
part, diffusion changes also take place in the GM and
have been described in recent papers [56, 57]. Although
there is some evidence that microstructural changes
come early in the pathological cascade, whether the
earliest changes occur in cortical regions or in WM fiber
fascicles is still under debate. This present study de-
scribes differences observed using a tract-based ana-
lysis technique. Although some methodological
warnings have been raised in relation to using this
technique, as described previously [58, 59], and al-
though the technique may not be used for areas other
than WM, it generally provides increased sensitivity
in the detection of changes along the most stable
fiber tracks and has been widely used as such in
many previous works reported in the literature. Never-
theless, we performed a complementary whole-brain voxel-
based (SPM) analysis using the same statistical models,
contrasts, and dataset (–Additional file 1: Appendix B). The
resulting significant clusters were exclusively located in the
WM without using any prior anatomical assumptions in the
detection. This would support the hypothesis that micro-
structural changes occur exclusively in the WM. However,
because previous studies have shown a nonmonoto-
nous behavior of cortical water diffusivity with pro-
gressive preclinical AD stages [56], we cannot rule
out the presence of significant effects on GM. Unfor-
tunately, the lack of core AD biomarkers in this study
prevented us from testing this hypothesis. Besides, it
could be argued that voxel-based analyses may suffer
from the inclusion of signal from cerebrospinal fluid
in GM voxels, which would reduce sensitivity within
cortical regions. To overcome this, one could then
consider opting for different methods, such as using
surface-based schemes [56], which would avoid
smoothing using a 3D kernel.
Samples of “healthy” participants are of high interest be-
cause they allow study of structural markers at an early
stage before deviating from the course of normal aging.
However, such studies are often limited by the lack of add-
itional markers that would discriminate preclinical subjects
at the earliest stages of AD, such as cerebrospinal fluid
markers and brain amyloid burden. Thus, such studies, in-
cluding this present one, face the risk of having individuals
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with preclinical AD overrepresented within their APOE-ε4
groups. To mitigate this, we will have access to follow-up
information that will allow us to better stratify our sample
with respect to preclinical AD research criteria [60] and to
minimize the risk of including persons with subtle cognitive
decline in the healthy group. In particular, a fraction of this
cohort will undergo complementary examination including
positron emission tomographic imaging and lumbar punc-
ture. (See [34] for a detailed description of the various arms
of the study.) To date, very few studies have included both
structural metrics (e.g., DTI and indices of AD pathology
such as cerebrospinal fluid and brain amyloid markers at
the preclinical stage). The screening of these individuals will
then allow the link between microstructure and cognition
to be investigated and compared between healthy and pre-
clinical subjects. A further reason for including study sub-
jects prior to development of disease would be to assess
how baseline diffusivity parameters may predict the time
before clinical onset, considering especially that APOE-ε4 is
known to have a lower age at onset, in a gene-dose-
dependent manner.
The major strength of our study lies in having re-
cruited a relatively young, cognitively healthy sample,
with a very large number of APOE-ε4 homozygotes. This
allowed us to study individuals at three levels of risk,
thus building on most published studies that compared
carriers vs noncarriers. Our findings are robust, as con-
firmed by several methodological approaches, and are
not driven by cerebrovascular disease, as confirmed by
ruling out any impact of WMH. However, there are
some limitations to our work. The most notable one is
that we do not know the amyloid status of the studied
participants. Cognitively healthy APOE-ε4 homozygotes
have been reported to show a significantly higher preva-
lence of cerebral amyloid pathology. At the mean age of
our homozygote group (55 years), approximately 50% of
these individuals display abnormal levels of amyloid bio-
markers, as compared with only 10% of noncarriers and
about 20% of carriers of a single ε4 allele [61]. However,
the lack of interaction with age in our findings, in agree-
ment with some previous reports [14, 18], is supportive of
our findings not being driven by amyloid status. The fact
that no inflection point in the association between RD was
found around this age supports the hypothesis that the
thinning of the myelin sheath is a genetically determined
trait in these subjects rather than a downstream effect of
amyloid deposition. dMRI studies in APOE-ε4 homozy-
gote children and adolescents are needed to confirm this
hypothesis. In middle-aged populations, amyloid bio-
markers and longitudinal data would obviously be neces-
sary to discern the influence of amyloid deposition in
dMRI scalars, and actually, some previous works suggest
that microstructural properties in the WM are subject to
the combined influence of age and genotype [12, 20].
Conclusions
Our results confirm that carrying the APOE-ε4 allele
confers an additional burden to the normal age-related
changes observed in WM in cognitively healthy individ-
uals. This burden emerges as differential changes in
dMRI parameters, essentially in diffusivity, suggesting
early affection of the fibers of the myelin sheath at a
stage predating axonal loss and typically resulting in de-
creases of anisotropy. With the uniquely high number of
homozygotes in our dataset, our study shows that carry-
ing two copies of the ε4 allele is also associated with a
significantly higher impact on the WM microstructure.
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